Candidemia in COVID‐19 treated with corticosteroids and tocilizumab

COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment.

Detalles Bibliográficos
Autores principales: Yamamoto, Koichiro, Nakamura, Kaoru, Hagiya, Hideharu, Otsuka, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455967/
https://www.ncbi.nlm.nih.gov/pubmed/34584718
http://dx.doi.org/10.1002/ccr3.4858
Descripción
Sumario:COVID‐19 patients treated with anti‐inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID‐19 treatment.

Ejemplares similares